id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1996-D-0048-0005,FDA,FDA-1996-D-0048,Q3B(R) Impurities in New Drug Products (Revision 2),Other,Guidance,2006-08-04T04:00:00Z,2006,8,2020-06-02T04:00:00Z,,2024-11-15T02:00:46Z,,1,0,09000064846c4e6f